Rajan Sharma
Stock Analyst at Goldman Sachs
(0.28)
# 4,149
Out of 4,868 analysts
5
Total ratings
25%
Success rate
-13.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $9.85 | -26.40% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $70.76 | +37.08% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $38.64 | +21.64% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $31.70 | +149.21% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $9.85
Upside: -26.40%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $70.76
Upside: +37.08%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $38.64
Upside: +21.64%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $31.70
Upside: +149.21%